We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

We recently published a list of 13 Best Cheap Stocks to Invest in for Beginners. In this article, we are going to take a look ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

Shares of Pfizer Inc. PFE advanced 2.63% to $22.60 Thursday, on what proved to be an all-around favorable trading session for ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

Last year was a strong one in terms of performance and execution by Pfizer, even though its stock took a hit in 2023 due to a decline in revenues and profits. It saw improved performance of its ...

Below is some historical data on the post-earnings performance of Pfizer stock compared to the stock performance of peers that reported their earnings just before Pfizer. For a fair comparison ...

The upcoming report from Pfizer (PFE) is expected to reveal ... earnings estimate revisions and the short-term price performance of a stock. While it's common for investors to rely on consensus ...

Pfizer PFE will report its first-quarter earnings ... The healthcare bellwether’s performance has been solid, with the company exceeding earnings expectations in each of the trailing four ...